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3. Progress Report  
Non-heme iron-containing oxygenases represent more than 80% of all know dioxygenases 
and a large number of mono-oxygenases, and thus, a definition of the molecular basis of 
their catalytic action is highly relevant to many key biological processes. The broad 
objectives of our research program are to continue our analysis of the involvement of 
non-heme iron in the catalytic pathway of bacterial dioxygenases, and to initiate com-
parative studies with mamalian mono-oxygenases containing functional non-heme iron or 
copper. In these studies we utilize physical techniques such as resonance Raman and EXAK 
chemical tecnhiques such as the design of transition state analogs and other active-site 
directed ligands, metal replacement and chemical modification; and rapid reaction kinetic 
techniques. 
The following paragraphs summarize our progress during the first year of this 
project. 
34S-Protocatechuate-3,4-dioxygenase (PCD): In previous studies of the resonance 
Raman spectra of PCD the.presence of a band at 274 cm -1 which disappears with substrate 
binding suggested to us the possible ligation of cysteine to iron in the active site. 
To test this possibility we decided to make 34S labeled PCD which sould show a shift in 
the 274 cm-1 band, if it indeed reflects sulfur ligation. 
To incorporate the labeled sulfur in the enzyme, cells were grown on a 
34S enriched 
medium developed specifically for this purpose in our laboratory. PCD was then isolated 
by our standard procedure to give an excellent yield of 200mg of 34S labeled PCD, with 
a specific activity of 70 U/mg. Resonance Raman spectroscopy of 34S-PCD showed no iso-
tope shifts from the spectrum of the native enzyme, thus providing strong support for 
the conclusion that the low frequency bands do not arise from sulfur ligation of the 
PHS-2590-1 
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active site iron. 
4Fe-PCD. In experiments complimentary to those described above, PCD in which 
the active site  irons were isotopically labeled was prepared by reconstitution of 
the apoenzyme with 54 Fe. We expected that Raman bands arising from iron ligands would 
exhibit the expected isotope shifts, thus providing further insight into the possible 
origins of low frequency bands in the 270 cm -1 region. ApoPCD with a specific activi-
ty of 0.51 U/mg was prepared from native PCD with a specific activity of 56 U/mg. 
Ferric oxide with 97.6% 34Fe was obtained from Oak Ridge National Laboratories and was 
reduced to metallic 54Fe. The metallic 54Fe was dissolved in slightly more than a 
two-fold excess of H 2SO4and base was added to just neutralize the pH. The so- 
lution was air dried and the 54FeS000H4)2-6H20 crystals were dried with acetone and 
used to reconstitute ApoPCD. Thc 54Fe labeled PCD had a specific activity of 49.7 U/mg. 
Resonance Raman spectra of the 54Fe labeled PCD showed that the band found at 274 cm -1 
 in nativePCD had shifted to 277 cm-1 . This suggests that the bands at 274 cm-1 in na-
tive PCD reflects an iron ligand bond, but the identity of the ligand is yet to be 
established. 
EXAFS Studies. In collaboration with Drs. Stern and Parson of the University of 
Washington, we have now successfully initiated EXAFS Studies with PCD, as set out in 
our proposal. A concern of the Study Section was that X-ray exposure might denature 
the protein but our owrk to date with PCD has clearly established that this will not 
be a problem. PCD samples were sent to the University of Wasington and EXAFS run at 
the Stanford accelerator, after which the enzyme was returned to us for assay and spec-
tral examination. No significant changes in either activity or spectral properties 
resulted from X-ray irradiation or shipment of the solutions. Although analysis of 
the data is not yet complete, the very exciting possibility has arisen that we may 
have obtained the first evidence fear a histidine ligand of the active-site iron of PCD. 
We are very much: encouraged by our success in these initial experiments, and our col-
laborators at the Univeristy of Washington have indicated that the data obtained are 
of high quality. Thus, during the coming year we anticipate being heavily involved 
in obtaining and analyzing EXAFS data both with PCD and other mono-oxygenases, such 
as Phenylalanine Hydroxylase and, possibly, Dopamine-{3-Hydroxylase. 
Transition-State Analogs. Our proposed studies with 2-hydroxypyridine-N-oxides 
as transition state analogs for PCD have produced very promising reuslts. To date, 
we have successfully completed the very difficult syntheses involved, fully charac-
terized the compounds, and established that our N-oxides are highly potent inhibitors 
for PCD. Stopped-flow kinetic experiments are now underway in order to characterize 
the binding events and differentiate ground state from transition state inhibition. 
It is our expectation that our results will provide strong support for the mechanistic 
proposals which we have previously made for non-heme iron dixygenase catalysis. 
Studies With Other Mono-oxygenases. In experiments which we did not forsee at the 
start of our program, we have 'pegun to obtain comparative specificity data regarding 
oxygenase catalysis which we anticipate will allow us to suggest a unified mechanism 
for enzymatic oxygenation reactions. Working with Dopamine-3-Hydroxylase we have es-
tablished two new activities for this enzyme -- stereospecific sulfoxidation of sul-
fides and ketonization of enantiomers of the normal hydroxylation product. We have now 
successfully carried out a systematic study of both the effects of substrate secondary 
structure and of various sutstituents on the sulfoxidation and hydroxylation reactions. 
Our results have allowed us to make direct mechanistic comparisons between Dopamine-{3-
Hydroxylase, Cytochrome-P-450 and chemical model systems, and we anticipate extending 
similar studies to Phenylalanine Hydroxylase in the near future. The specific details 
of our mechanistic suggestions will not be presented in this brief report, but are 
fully discussed in a paper which is in press in the Journal of Biological Chemistry. 
Copies of reprints will, of course, be provided when available. 
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During the coming year, our objectives are to continue and amplify our EXAFS 
studies with both PCD and mono-oxygenase enzymes, to complete the characterization 
of our transition state analogs for PCD, and to continue our mechanistic studies 
aimed at providing unified mechanistic information about the pathway of enzymatic 
oxygenation reactions. In our view, enough of the preliminary work has now been 
successfully completed so that we can confidently expect to meet these objectives 
during the coming year. As always, we are grateful to the National Institutes of 
Health for continued support of our research efforts. 
